Technical Analysis for EVFM - Evofem Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
3.31 | 0.61% | 0.02 |
EVFM closed up 0.61 percent on Friday, June 5, 2020, on 4.02 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical EVFM trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Volume Surge | Other | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 0.61% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2020
- Sector: Healthcare
- Industry: Biotechnology
Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products. Its lead product candidate is Amphora, a non-hormonal woman-controlled vaginal gel, which is in Phase 3 clinical trial for the prevention of pregnancy; and in Phase 2b trial for the prevention of chlamydia and gonorrhea in women. The company is also developing multi-purpose vaginal pH regulator gel product candidate for the reduction of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Biopharmaceutical Health Medical Specialties Sexually Transmitted Diseases And Infections Gynaecology Human Reproduction Vagina
Biopharmaceutical Health Medical Specialties Sexually Transmitted Diseases And Infections Gynaecology Human Reproduction Vagina
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.5 |
| 52 Week Low | 3.2 |
| Average Volume | 1,852,822 |
| 200-Day Moving Average | 5.35 |
| 50-Day Moving Average | 5.05 |
| 20-Day Moving Average | 4.88 |
| 10-Day Moving Average | 4.74 |
| Average True Range | 0.53 |
| ADX | 16.74 |
| +DI | 18.94 |
| -DI | 36.69 |
| Chandelier Exit (Long, 3 ATRs ) | 5.27 |
| Chandelier Exit (Short, 3 ATRs ) | 4.80 |
| Upper Bollinger Band | 6.31 |
| Lower Bollinger Band | 3.45 |
| Percent B (%b) | -0.05 |
| BandWidth | 58.60 |
| MACD Line | -0.33 |
| MACD Signal Line | -0.10 |
| MACD Histogram | -0.2319 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.58 | ||||
| Resistance 3 (R3) | 3.61 | 3.54 | 3.54 | ||
| Resistance 2 (R2) | 3.54 | 3.47 | 3.53 | 3.52 | |
| Resistance 1 (R1) | 3.43 | 3.43 | 3.40 | 3.40 | 3.50 |
| Pivot Point | 3.36 | 3.36 | 3.35 | 3.35 | 3.36 |
| Support 1 (S1) | 3.25 | 3.29 | 3.22 | 3.22 | 3.12 |
| Support 2 (S2) | 3.18 | 3.25 | 3.17 | 3.10 | |
| Support 3 (S3) | 3.07 | 3.18 | 3.09 | ||
| Support 4 (S4) | 3.04 |
